SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-014266
Filing Date
2017-07-27
Accepted
2017-07-27 16:01:10
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q snss-10q_20170630.htm 10-Q 1170507
2 EX-10.1 snss-ex101_673.htm EX-10.1 105895
3 EX-31.1 snss-ex311_411.htm EX-31.1 16810
4 EX-31.2 snss-ex312_410.htm EX-31.2 16875
5 EX-32.1 snss-ex321_409.htm EX-32.1 6388
6 GRAPHIC g201707271535364544874.jpg GRAPHIC 3336
  Complete submission text file 0001564590-17-014266.txt   4191623

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snss-20170630.xml EX-101.INS 811979
8 XBRL TAXONOMY EXTENSION SCHEMA snss-20170630.xsd EX-101.SCH 38720
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20170630_cal.xml EX-101.CAL 38357
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20170630_def.xml EX-101.DEF 103879
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20170630_lab.xml EX-101.LAB 274271
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20170630_pre.xml EX-101.PRE 182230
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 17986214
SIC: 2834 Pharmaceutical Preparations